|
1 |
The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC‐II molecules
Enthalten in European Molecular Biology Organization: EMBO reports 10.10.2022. 25 S.
|
|
|
2 |
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients
Sadovnick, A. Dessa. - Würzburg : Universität Würzburg, 2020
|
|
|
|
3 |
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
Enthalten in Nature Communications Bd. 9, 25.1.2018, Nr. 1, date:12.2018: 1-17
|
|
|
|
4 |
CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis
Enthalten in Nature Communications Bd. 15, 12.6.2024, Nr. 1, date:12.2024: 1-15
|
|
|
|
5 |
Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial
Enthalten in BMC cancer Bd. 22, 13.12.2022, Nr. 1, date:12.2022: 1-9
|
|
|
|
6 |
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
Enthalten in BMC cancer Bd. 18, 30.1.2018, Nr. 1, date:12.2018: 1-2
|
|
|
|
7 |
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
Enthalten in BMC cancer Bd. 17, 16.8.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
8 |
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
Enthalten in Acta neurologica Belgica Bd. 118, 27.1.2018, Nr. 1, date:3.2018: 7-11
|
|
|
|
9 |
Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020)
Enthalten in BMC infectious diseases Bd. 22, 28.9.2022, Nr. 1, date:12.2022: 1-14
|
|
|
|
10 |
ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies
Enthalten in BMC cancer Bd. 23, 9.3.2023, Nr. 1, date:12.2023: 1-9
|
|
Administration
